Dapagliflozin 10 mg Tab

DRUG2 trials

Sponsors

Centre Hospitalier Universitaire Saint Pierre, Anemia Working Group Romania

Conditions

Chronic Kidney DiseasesDiabetes Mellitus, Type 2Type 2 Diabetes Mellitus

Phase 4

Effect of the Antidiabetic Drug Dapagliflozin on the Coronary Macrovascular and Microvascular Function in Type 2 Diabetic Patients

TerminatedNCT05392959

Centre Hospitalier Universitaire Saint PierreDiabetes Mellitus, Type 2

Start: 2022-06-06End: 2023-07-17Updated: 2024-04-26

Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus

RecruitingNCT06281899

Anemia Working Group RomaniaChronic Kidney Diseases, Type 2 Diabetes Mellitus

Start: 2022-01-01End: 2025-03-31Target: 200Updated: 2024-02-28

Related Papers

#2917 Efficacy and safety of low protein diet on top of SGLT2i regarding glycemic control in patients with CKD and type 2 DM

Nephrology Dialysis Transplantation2025-10-01